Paediatric Asthma Study
About This Study:
This study focuses on improving treatment for children with asthma, aiming to reduce symptoms and prevent attacks through innovative therapies.
Who Can Participate?
Children aged 6 to 17 diagnosed with asthma, under parental/guardian consent.
What to Expect:
Regular clinic visits, supervised medication administration, and health monitoring by experienced paediatric specialists.
Benefits of Participation:
- Access to cutting-edge paediatric asthma treatments
- Comprehensive medical care
- Supporting research that benefits children with asthma
Ready to make a difference?
Interested in joining this study?
Participation involves screening for eligibility, informed consent, and regular visits with our clinical team.
Our staff will guide you throughout the process, prioritising your safety and comfort.